Stonebridge Capital Advisors LLC Viatris Inc Transaction History

Stonebridge Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$9.59 - $11.35 $86 - $102	9 Added 0.47%	1,929 $19,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $2,244 - $2,991	-244 Reduced 11.28%	1,920 $18,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $130 - $173	-15 Reduced 0.69%	2,164 $24,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $1,560 - $2,047	-184 Reduced 7.79%	2,179 $19,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $1,542 - $1,901	155 Added 7.02%	2,363 $25,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $568 - $893	-58 Reduced 2.56%	2,208 $24,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $205 - $249	17 Added 0.76%	2,266 $31,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $265 - $302	-20 Reduced 0.88%	2,249 $30,000
Q2 2021 Aug 20, 2021	SELL	$12.97 - $16.15 $453 - $565	-35 Reduced 1.52%	2,269 $32,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $31,311 - $42,716	2,304 New	2,304 $32,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.